An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
This purpose of this study is to evaluate the pharmacokinetics (PK), safety, and tolerability of bedaquiline (BDQ) in...
